AIM ImmunoTech Inc. Soared

AIM ImmunoTech Inc. (AIM:NYSEMKT) rocketted at $1.02, a gain of 43.7%. On Wed, Mar 18, 2026, AIM:NYSEMKT hit a New 2-Week High of $1.02. The stock got featured on our News Catalysts scanner on Wed, Mar 18, 2026 at 10:03 AM in the 'BIOTECH' category. From Wed, Mar 04, 2026, the stock recorded 50.00% Up Days and 27.27% Green Days

The stock spiked on Wed, Mar 18, 2026 at $1.62 with a volume of 183M+.

About AIM ImmunoTech Inc. (AIM:NYSEMKT)

AIM ImmunoTech Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the experimental therapeutic Ampligen. Alferon N Injection is approved for a category of STD infection, and Ampligen represents a RNA being developed for viral diseases and disorders of the immune system. The sales revenue of the company is derived from the United States.